azacitidine,venetoclax,pivekimab sunirine
abbvie,roche,immunogen
['azacitidine,(-oral azaci),(-azacitidine oral)', 'venetoclax', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'pivekimab', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'leukemia', 'myeloid', 'imab ']
dr. gail roboz shares research from #ash22 studying the effect of a cd123-targeted combination therapy for relapsed/refractory acute myeloid #leukemia. 
The Leukemia and Bone Marrow Failure Program at Weill Cornell Medicine offers a comprehensive approach to acute and chronic leukemias, MPDs and MDS.